Literature DB >> 8453494

Dexfenfluramine induces Fos-like immunoreactivity in discrete brain regions in rats.

B H Li1, N E Rowland.   

Abstract

Administration of the anorectic agent, dexfenfluramine (DFEN) to rats induced dose- and time-dependent expression of Fos-like immunoreactivity in several discrete brain regions of rats. At moderate doses, the regions showing the most intense Fos immunostaining included the bed nucleus of the stria terminalis, the lateral part of the central amygdala, midline thalamic nuclei, habenular nuclei, lateral parabrachial nucleus, and nucleus of the solitary tract. It is suggested that these nuclei, many of which are known to receive gustatory or visceral input, may form part of a functional circuit via which DFEN modulates food intake. Rats that were made hungry by either food deprivation or administration of insulin also showed induction of Fos in several brain regions, but only that in the supramamillary/ventral tegmental area was suppressed by pretreatment with an anorectic dose of DFEN. The functional significance of these sites requires further investigation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8453494     DOI: 10.1016/0361-9230(93)90009-z

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  9 in total

1.  Immediate-early gene expression in the brain of the thiamine-deficient rat.

Authors:  A S Hazell; L McGahan; W Tetzlaff; A M Bedard; G S Robertson; Y Nakabeppu; A M Hakim
Journal:  J Mol Neurosci       Date:  1998-02       Impact factor: 3.444

2.  Effect of serotonergic anorectics on food intake and induction of Fos in brain of mice with disruption of melanocortin 3 and/or 4 receptors.

Authors:  Neil E Rowland; Kaihan J Fakhar; Kimberly L Robertson; Carrie Haskell-Luevano
Journal:  Pharmacol Biochem Behav       Date:  2010-03-27       Impact factor: 3.533

3.  Brain-derived neurotrophic factor-deficient mice develop aggressiveness and hyperphagia in conjunction with brain serotonergic abnormalities.

Authors:  W E Lyons; L A Mamounas; G A Ricaurte; V Coppola; S W Reid; S H Bora; C Wihler; V E Koliatsos; L Tessarollo
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

4.  Food demand and meal size in mice with single or combined disruption of melanocortin type 3 and 4 receptors.

Authors:  Deniz Atalayer; Kimberly L Robertson; Carrie Haskell-Luevano; Amy Andreasen; Neil E Rowland
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-04-07       Impact factor: 3.619

Review 5.  Etiology, triggers and neurochemical circuits associated with unexpected, expected, and laboratory-induced panic attacks.

Authors:  Philip L Johnson; Lauren M Federici; Anantha Shekhar
Journal:  Neurosci Biobehav Rev       Date:  2014-08-15       Impact factor: 8.989

6.  Absence of fenfluramine-induced anorexia and reduced c-Fos induction in the hypothalamus and central amygdaloid complex of serotonin 1B receptor knock-out mice.

Authors:  J J Lucas; A Yamamoto; K Scearce-Levie; F Saudou; R Hen
Journal:  J Neurosci       Date:  1998-07-15       Impact factor: 6.167

Review 7.  Addiction-related gene regulation: risks of exposure to cognitive enhancers vs. other psychostimulants.

Authors:  Heinz Steiner; Vincent Van Waes
Journal:  Prog Neurobiol       Date:  2012-10-17       Impact factor: 11.685

8.  Distribution and neurochemical characterization of neurons within the nucleus of the solitary tract responsive to serotonin agonist-induced hypophagia.

Authors:  Daniel D Lam; Ligang Zhou; Andreas Vegge; Philip Y Xiu; Britt T Christensen; Mayowa A Osundiji; Chen-yu Yueh; Mark L Evans; Lora K Heisler
Journal:  Behav Brain Res       Date:  2008-08-13       Impact factor: 3.332

9.  Serotonin activates the hypothalamic-pituitary-adrenal axis via serotonin 2C receptor stimulation.

Authors:  Lora K Heisler; Nina Pronchuk; Katsunori Nonogaki; Ligang Zhou; Jacob Raber; Loraine Tung; Giles S H Yeo; Stephen O'Rahilly; William F Colmers; Joel K Elmquist; Laurence H Tecott
Journal:  J Neurosci       Date:  2007-06-27       Impact factor: 6.167

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.